UDG Healthcare PLC

UDG Healthcare PLC

Health CareHealth Care Equipment & Services
  • Price (GBX)662.50
  • Today's Change12.00 / 1.84%
  • Shares traded546.00k
  • 1 Year change43.93%
  • Beta0.8424
Data delayed at least 20 minutes, as of Oct 26 2016 15:59 BST.
More ▼

Key statistics

As of last trade UDG Healthcare PLC (UDG:LSE) traded at 662.50, -1.34% below its 52-week high of 671.50, set on Oct 24, 2016.
52-week range
452.20Oct 26 2015671.50Oct 24 2016
Markit short selling activity
Previous close650.50
Average volume513.39k
Shares outstanding246.76m
Free float209.10m
P/E (TTM)33.87
Market cap1.63bn GBP
EPS (TTM)0.1951 GBP
Annual div (IAD)10.72 GBX
Annual div yield (IAD)1.62%
Div ex-dateMay 26 2016
Div pay-dateJun 20 2016
Data delayed at least 20 minutes, as of Oct 26 2016 15:59 BST.
More ▼

Investors Chronicle View

The last IC recommendation on UDG Healthcare PLC shares was Buy at 596.00 on 20 May 2016Read the full article

Board of Directors


Peter Gray, Chairman


Brendan McAtamney, Chief Operating Officer


Alan Ralph, Chief Financial Officer


Chris Corbin, Managing Director of Ashfield Commercial and Medical Services


Liam FitzGerald, Non-Executive Director


Chris Brinsmead, Non-Executive Director


Gerard van Odijk, Non-Executive Director


Lisa Ricciardi, Non-Executive Director


Philip Toomey, Non-Executive Director


Linda Wilding, Non-Executive Director

Introduction to UDG Healthcare plc

Investor Relations Contact

Alan Ralph
UDG Healthcare House
Magna Drive
Magna Business Park
Citywest Road
Dublin 24
David Marshall
Head of Investor Relations
UDG Healthcare House
Magna Drive
Magna Business Park
Citywest Road
Dublin 24
Tel: +353 1 463 2300
Fax: +353 1 459 6893
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.